M2 macrophages in kidney disease: biology, therapies, and perspectives

Kidney Int. 2019 Apr;95(4):760-773. doi: 10.1016/j.kint.2018.10.041. Epub 2019 Mar 1.

Abstract

Tissue macrophages are crucial players in homeostasis, inflammation, and immunity. They are characterized by heterogeneity and plasticity, due to which they display a continuum of phenotypes with M1/M2 presenting 2 extremes of this continuum. M2 macrophages are usually termed in the literature as anti-inflammatory and wound healing. Substantial progress has been made in elucidating the biology of M2 macrophages and their potential for clinical translation. In this review we discuss the current state of knowledge in M2 macrophage research with an emphasis on kidney disease. We explore their therapeutic potential and the challenges in using them as cellular therapies. Some new regulators that shape macrophage polarization and potential areas for future research are also examined.

Keywords: M2; anti-inflammatory; kidney disease; macrophage; polarization; therapy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Humans
  • Inflammation Mediators / immunology
  • Inflammation Mediators / metabolism
  • Kidney Diseases / immunology
  • Kidney Diseases / therapy*
  • Macrophage Activation / drug effects
  • Macrophage Activation / genetics
  • Macrophage Activation / immunology*
  • Macrophages / immunology
  • Macrophages / metabolism
  • Macrophages / transplantation*

Substances

  • Inflammation Mediators